Latest News
JPMorgan downgrades Informa as it waits for business travel to return
JPMorgan Cazenove downgraded its stance on shares of Informa to ‘neutral’ from ‘overweight’ on Thursday and slashed the price target to 389p from 528p as it waits for business travel to return.
Breedon delivers 'encouraging' performance as demand recovers
Construction materials group Breedon said on Thursday that it had continued to deliver an "encouraging" performance since seeing demand begin to return in early May.
Novacyt swings to profit on soaring Covid test sales
Covid-19 test maker Novacyt swung to a first-half profit driven by soaring sales during the current pandemic and said it expected core annual earnings to top €100m.
IronRidge upbeat on latest drilling results at Zaranou
Africa-focussed minerals exploration company IronRidge Resources reported additional high-grade drilling results from the second phase drilling programme at the Ebilassokro and Ehuasso targets, both within the Zaranou Gold Project area, on Thursday.
Morses Club in-home sales and repayments decline in H1
Doorstop lender Morses Club said on Thursday that home collected credit sales and repayments had both declined during the six months ended 31 August.
Co-operative H1 profits rise on ‘exceptional’ food, wholesale performances
The Co-operative Group reported a rise in first-half profits on Thursday as revenue was boosted by the food and wholesale divisions.
EU car sales slow as demand eases
EU car sales slowed in August as demand built up during the Covid-19 lockdowns slowed, industry figures showed.
OptiBiotix Health strikes deal with Ayalla in Brazil
Life sciences company OptiBiotix Health announced on Thursday that its wholly-owned subsidiary ProBiotix Health has entered into an exclusive distribution agreement with Ayalla Marketing, for the distribution of its cholesterol reducing probiotic ‘LPLDL’ as an ingredient and as four finished products within the ‘CholBiome’ portfolio, for Brazil.
Europe open: Shares open weaker on Fed news; waiting on BoE
European shares opened weaker on Thursday as investors weighed the US Fed decision overnight to leave interest rates at near-zero until at least 2023.
Trainline reports gradual recovery after lockdown collapse in demand
Trainline said on Thursday that the impact of Covid-19 resulted in its net ticket sales decreasing to £358m in the first half, equivalent to 19% of the same period in the prior year.
Vesuvius pays back Covid-19 debt to BoE
Vesuvius said on Thursday that it has elected to repay £200m of debt issued through the Bank of England’s Covid Corporate Financing Facility earlier than its March 2021 maturity thanks to positive free cash flow generation in recent months and early signs of "marginally improving" levels of business activity.
Playtech reports strong trading after profit drops
Playtech reported strong but weakening summer trading as the gambling software company posted a sharp fall in first-half profit caused by the Covid-19 crisis.
LXI REIT raises quarterly dividend guidance
Real estate investment trust LXI upped its quarterly dividend guidance on Thursday after experiencing some "robust rent collection" in the three months ending 30 September.
London open: Stocks fall as investors eye BoE announcement
London stocks fell in early trade on Thursday as investors digested the latest rate decision from the US Federal Reserve and looked ahead to a policy announcement from the Bank of England.
Grainger gets green light for Southall development from Ealing Council
Residential property group Grainger has been given the green light by Ealing Council for a new development by Southall station.
Hilton Foods lifts dividend as home dining boosts profits
International food packing business Hilton Food lifted its dividend after a sharp rise in interim profits driven by higher volumes.
Rolls-Royce still reviewing funding options
Rolls-Royce is still reviewing a range of funding options to strengthen its balance sheet including debt and equity, but no final decisions have been made, the engine maker said.
Next upgrades profit guidance as sales beat expectations
Next upgraded its profit guidance after sales in the first half and beyond held up better than the company expected.
Oxford Biomedica flags decent second half, Trainline reports recovering demand
London open The FTSE 100 is expected to open 66 points lower on Thursday, having closed down 0. 44% at 6,078. 48 on Wednesday.
Oxford Biomedica sees swing to FY profit on Covid vaccine hopes
Drugs maker Oxford Biomedica, which has partnered with pharma giant AstraZeneca to develop a Covid-19 vaccine, said it expected higher second half revenues to push it to a low-to-single digit full year profit.